Value-for-money UPC is worth it says GSK corporate counsel | Court offers alternative to costly US litigation | Head of ...

Roche’s chief trademark officer has more than filing and searches on his to-do list—and external counsel must keep up, he ...

Duo successfully invalidate two CureVac patents in the UK | High Court deems patents invalid due to lack of inventive step and insufficient technical contribution | CureVac “disappointed” but stressed ...

A UK court upholds the patent for Astellas Pharma's life-extending prostate cancer treatment | Judgment dismisses attempts by ...

7 March 2022 Regeneron has failed to convince a Manhattan district court to drop a lawsuit claiming that it developed ...